121 related articles for article (PubMed ID: 6283618)
21. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay.
Brown TD; Ernberg I; Lamon EW; Klein G
Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574
[No Abstract] [Full Text] [Related]
22. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
Demissie A
J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
[No Abstract] [Full Text] [Related]
23. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
Klein G; Dombos L; Gothoskar B
Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
[No Abstract] [Full Text] [Related]
24. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
Svedmyr A; Demissie A; Klein G; Clifford P
J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
[No Abstract] [Full Text] [Related]
25. The Epstein-Barr virus (EBV): evidence for EBV strains.
Menezes J; Leibold W; Klein G
IARC Sci Publ (1971); 1975; (11 Pt 1):323-30. PubMed ID: 190135
[No Abstract] [Full Text] [Related]
26. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
27. The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.
Falser N
Arch Otorhinolaryngol; 1984; 239(1):15-23. PubMed ID: 6318710
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of Epstein-Barr virus. II. Induction of early antigens (EA) by complementation.
zur Hausen H; Fresen KO
Virology; 1977 Aug; 81(1):138-43. PubMed ID: 196397
[No Abstract] [Full Text] [Related]
29. Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma.
Henle G; Henle W
Bibl Haematol; 1975 Oct; (43):322-5. PubMed ID: 183692
[No Abstract] [Full Text] [Related]
30. Epstein-Barr virus viral capsid antigen titer by immunofluorescence with microplates: new semiautomated method based on the microtiter system.
Lamy ME; Favart AM; Burtonboy G; Arana A
J Clin Microbiol; 1977 Jul; 6(1):66-71. PubMed ID: 195981
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassay for Epstein--Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigen immobilized in polyacrylamide gel.
Dölken G; Klein G
Eur J Cancer (1965); 1977 Nov; 13(11):1277-86. PubMed ID: 73461
[No Abstract] [Full Text] [Related]
32. Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.
Dölken G; Weitzmann U; Boldt C; Bitzer M; Brugger W; Löhr GW
J Immunol Methods; 1984 Mar; 67(2):225-33. PubMed ID: 6323578
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
Yang CS; Hewetson JF
Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
[No Abstract] [Full Text] [Related]
34. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
[No Abstract] [Full Text] [Related]
35. Detection of IgG antibody to Epstein-Barr virus viral capsid antigen in saliva by antibody capture radioimmunoassay.
Vyse AJ; Knowles WA; Cohen BJ; Brown DW
J Virol Methods; 1997 Jan; 63(1-2):93-101. PubMed ID: 9015279
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma.
Gunvén P; Klein G; Henle G; Henle W; Clifford P; Singh S
Bibl Haematol; 1973; 39():813-7. PubMed ID: 4360196
[No Abstract] [Full Text] [Related]
37. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients.
Biggar RJ; Pandey JP; Henle W; Nkrumah FK; Levine PH
Int J Cancer; 1984 May; 33(5):577-80. PubMed ID: 6327537
[TBL] [Abstract][Full Text] [Related]
38. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and Burkitt lymphoma.
Lancet; 1978 Sep; 2(8089):561. PubMed ID: 79925
[No Abstract] [Full Text] [Related]
40. Epstein-Barr virus nuclear antigen (EBNA)-positive cells in a lymph-node of a child with severe primary EBV infection.
Lenoir G; De-The G; Virelizier JL; Griscelli C
IARC Sci Publ (1971); 1978; (24 Pt 2):733-8. PubMed ID: 221396
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
